WO2001028428A1 - Sample taking device - Google Patents
Sample taking device Download PDFInfo
- Publication number
- WO2001028428A1 WO2001028428A1 PCT/GB2000/003983 GB0003983W WO0128428A1 WO 2001028428 A1 WO2001028428 A1 WO 2001028428A1 GB 0003983 W GB0003983 W GB 0003983W WO 0128428 A1 WO0128428 A1 WO 0128428A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- probe
- sampler device
- sample
- reservoir
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/90—Identification means for patients or instruments, e.g. tags
- A61B90/94—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text
- A61B90/96—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text using barcodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0096—Casings for storing test samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B2010/0009—Testing for drug or alcohol abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B50/00—Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers
- A61B2050/005—Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers with a lid or cover
- A61B2050/0067—Types of closures or fasteners
- A61B2050/0083—Snap connection
Definitions
- This invention relates to a portable device for taking samples from subjects for testing the presence of drugs or other substances in the body, and for storage of samples.
- Drug abuse extends to all walks of life and persons in positions of trust such as heavy plant operators, airline pilots, train drivers, bus drivers etc. are sometimes randomly or routinely tested for drug abuse.
- Current devices for testing for drugs are time consuming, cumbersome and require specialist knowledge to operate and frequently rely upon taking a blood sample from a subject
- Samples taken from a subject alternatively or additionally may be held in storage for other tests in particular DNA tests. In this case it is desirable that test samples should be held in safe storage for prolonged periods of time until further tests, or research can be carried out.
- the present invention provides a simple device for taking an sample from the mouth of a subject and storage means for storing said device and sample in a tamper evident container.
- a sampler device comprising a probe for taking a sample, and a container into which the probe is an irreversible snap-fit after the taking of the sample.
- the probe is preferably shaped for taking material from the gingival cavity of mammals.
- the probe further comprises a stem with a handle and a shield located between the handle and the stem.
- the shield forms a snap-fit lid to the container after the stem is inserted into the container and may include a sealing lip on the side of the shield adjacent the stem for sealing the container once the sample probe is retained therein.
- the distal end portion of the stem has an absorbent sample collecting area which absorbs bodily exudates, preferably from inside the mouth and jaw.
- the absorbent area comprises a pad of high salt concentrate which is covered in a semi-permeable membrane.
- the container comprises and inner liquid retaining reservoir and an outer plastic sleeve cover into which the reservoir is sealed, the cover having an aperture with a tear-away lid, which aperture may closed after removal of the lid, by the probe when inserted.
- the shield forms the snap-in lid for said aperture and the seal on the shield sits against the reservoir.
- Each handle and/or cover may be given a unique bar code so that taken samples once sealed into the container cannot be mixed up or wrongly identified with other samples.
- the handle and/or shield may be formed with a thinned down area to guide and permit a hyperdermic needle to be inserted through the lid for removing test samples from the container, and preferably the handle has a guide channel to the thinned area.
- the reservoir may be formed from an optically transparent material e.g. glass or transparent plastics material, and the sleeve has openings therein on opposite sides of the reservoir to allow a directed light beam to pass through the container to excite or illuminate any suitable chemical solution stored within the reservoir.
- the openings are located in the lower portion of the container so that any light beam passing through the container will not be distorted by the meniscus of any solution at the correct level within the reservoir.
- a combination of enzymes and antibodies may be targeted at the direct metabolites of drugs and these may be detected in fluoroscene based solutions using optical transmissions through the solution to excite any the metabolites or derivatives thereof, as is described in US patent 5164504.
- Other materials may be tested in situ in the tube using other chemistries and various light transmission and absorption techniques.
- the container may be formed as a one piece container having optical windows formed in the lower half of the container.
- a sample container having an aperture with a tear-away portion lid allowing a sample to be placed in the container through the aperture, and an irreversible snap fit lid which is insertable into the aperture to lock the sample therein.
- Fig. 1 is a side view of a sample taking probe
- Fig. 2 is an end elevation of the probe of Fig.l
- Fig. 3 is a side view of a container reservoir
- Fig. 4 is an end elevation of the reservoir of Fig.2
- Fig. 5 is a side view of a container cover which fits over the reservoir
- Fig. 6 is an end elevation of the cover shown in Fig.5
- Fig. 7 is a side view of the cover and reservoir when assembled
- Fig. 8 is an end view of the assembly of Fig.7
- Fig. 9 is a side view of the container and probe in an assembled state
- Fig. 10 is an end view of the container and probe shown in Fig 9
- Fig. 11 shows an alternative container in the open and closed conditions.
- a probe 11 for taking samples from the mouth or jaw of a person or animal suspected of drug abuse.
- the probe 11 has a stem 12 with a handle 13 at one end with transverse rectangular shield 14 located between the stem and handle.
- the distal end portion 15 of the stem is broadened out and has pad 16 on each side of the end portion which is formed from an absorptive material .
- an absorptive material is a hypertonic salt as is described in US 5830 410.
- the shield 14 on its side adjacent the stem 12 has a pair of resilient undercut catches 17 at opposite ends thereof, and a rectangular collar 18 around the stem 12.
- the collar 18 has a peripheral seal 19 formed thereon.
- the handle 13 may have a vertical channel 20 located therein extending into the shield to form a thinned or weakened area 20A which permits easier penetration of a hyperdermic needle allowing the extraction of fluids for tests. The rupture of the area 20A will also indicate if a sample has been tampered with.
- a container 70 which will be used together with the probe 11.
- the container comprises an inner reservoir 20 and an outer sleeve-like cover 40.
- the reservoir 20 is shown in detail in Figs 3 & 4 and comprises a rectangular section hollow body made from an optically transparent material such as glass, or plastics material e.g polystyrene, thermoplastic polyester, polymethylmethacrylate etc.
- the reservoir body 20 has an opening 21 at its upper end surrounded by a flat peripheral lip 22.
- a seal 23 is set back from the upper end of the body 20 and in use co-operates with a recess in the cover 40.
- An indicator mark 24 on the side of the tube indicates the level to which the reservoir should be filled with chemical solutions.
- the reservoir is filled through the opening 21 with a suitable solution of detection chemicals which react with a sample contained on the probe.
- the cover 40 is best shown in Figs 5 & 6. and comprises a sleeve-like body having a rectangular section cavity 41 with an opening 47 at its upper end sealed by a tear-off closure 42 and which is open at its lower end to receive a reservoir 20.
- a tab 43 on the closure 42 assists removal of the closure 42 in use.
- the cavity 41 accommodates the reservoir 20 which is a sliding fit therein.
- a peripheral recess 44 in the inner surface of the cavity is set back from closure 42 and in use cooperates with the seal 23 on the reservoir body 20.
- Cut-outs or openings 45 are located on opposite sides of the cover 40. The cut outs are preferably in the form of arches and have inclined edges 46, the use of which will explained later in the text.
- the reservoir 20 is filled with detection solution and is then assembled within the cover 40.
- the seal 23 on the reservoir engages in the recess 44 to both seal the solution in the assembled container 70 and locks the reservoir within the cover.
- the container 70 is now both tamper evident and tamper proof.
- the probe and assembled container are supplied as a matched pair in sealed bags.
- the distal end portion 15 of the probe 11 is placed in a suspects mouth between the gums and the cheek for a predetermined time period, probably about three minutes.
- the pads 16 collect the bioexudate.
- the shield 14 prevents any cross contamination between the handle and the stem and between the testers hands and suspects mouth.
- the cover 42 is removed from the sealed container 70 by tearing off said cover, and the stem 12 of the probe 11 is pushed into the solution within the reservoir 20.
- the catches 17 on the shield 14 engage within opening 47 on the cover to lock the probe within the container 70.
- the seal 19 on the shield seats against the lip 22 around the mouth 21 of the reservoir to seal the taken sample and detection fluid within the container.
- the locked in probe provides a tamper evident closure device once the sample has been placed within the detection fluid and the shield 14 snapped into place.
- the assembled probe/container may now be placed into an optical testing instrument or reader, which forms no part of the present invention, and which may operate by for example, light absorption techniques such as luminescence, fluoroscene, and colorimetric techniques.
- the cut-outs 45 in the lower portion of the cover allow for optical transmission through the reservoir 20 and detection fluid when the container is placed in the reader so that integrity of the sample and test fluid is not breached for testing.
- the arch shaped inclined edges 46 to the cut outs provide a location device within the reader and light proof seals.
- the cut outs 45 are located in the lower portion of the container to prevent any optical interference between the meniscus of the solution within the container 70 and any light beam passed through the sample during the reading of the test instrument.
- the handle 13 of the probe and/or the container 70 may carry a bar code which can be assigned to a particular suspect in order to prevent mis matches between samples and suspects.
- the container 170 may be formed as a single hollow component with an optically clear window 175 provided in the lower portion of the fluid container.
- the container is provided with a tear-off closure 172 as before allowing a probe to be inserted and locked within the container.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001531028A JP2003511186A (en) | 1999-10-18 | 2000-10-17 | Sampling device |
CA002386987A CA2386987A1 (en) | 1999-10-18 | 2000-10-17 | Sample taking device |
EP00968131A EP1223866A1 (en) | 1999-10-18 | 2000-10-17 | Sample taking device |
AU78085/00A AU7808500A (en) | 1999-10-18 | 2000-10-17 | Sample taking device |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9924449.3 | 1999-10-18 | ||
GBGB9924449.3A GB9924449D0 (en) | 1999-10-18 | 1999-10-18 | Rapid drug detection system |
GB0021698A GB2355525A (en) | 1999-10-18 | 2000-09-05 | Sampling device for oral cavity |
GB0021698.6 | 2000-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001028428A1 true WO2001028428A1 (en) | 2001-04-26 |
Family
ID=26244964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/003983 WO2001028428A1 (en) | 1999-10-18 | 2000-10-17 | Sample taking device |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1223866A1 (en) |
JP (1) | JP2003511186A (en) |
CN (1) | CN1379641A (en) |
AU (1) | AU7808500A (en) |
CA (1) | CA2386987A1 (en) |
WO (1) | WO2001028428A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1389445A2 (en) * | 2002-08-14 | 2004-02-18 | Cozart Bioscience Limited | An oral fluid collection, testing and transportation device and method |
EP1692255A2 (en) * | 2003-11-12 | 2006-08-23 | Trustees Of Boston University | Isolation of nucleic acid from mouth epithelial cells |
JP2014153127A (en) * | 2013-02-06 | 2014-08-25 | Railway Technical Research Institute | Specimen sampler for urine dirt of toilet determination, urine dirt of toilet determination kit, and determination method of urine dirt of toilet |
US9920374B2 (en) | 2005-04-14 | 2018-03-20 | Trustees Of Boston University | Diagnostic for lung disorders using class prediction |
US10526655B2 (en) | 2013-03-14 | 2020-01-07 | Veracyte, Inc. | Methods for evaluating COPD status |
US10570454B2 (en) | 2007-09-19 | 2020-02-25 | Trustees Of Boston University | Methods of identifying individuals at increased risk of lung cancer |
US10731223B2 (en) | 2009-12-09 | 2020-08-04 | Veracyte, Inc. | Algorithms for disease diagnostics |
US10927417B2 (en) | 2016-07-08 | 2021-02-23 | Trustees Of Boston University | Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions |
US11639527B2 (en) | 2014-11-05 | 2023-05-02 | Veracyte, Inc. | Methods for nucleic acid sequencing |
US11977076B2 (en) | 2006-03-09 | 2024-05-07 | Trustees Of Boston University | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
US12110554B2 (en) | 2009-05-07 | 2024-10-08 | Veracyte, Inc. | Methods for classification of tissue samples as positive or negative for cancer |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104434227B (en) * | 2013-09-21 | 2017-05-10 | 邹建文 | Once-reciprocating self-locking oral cell sampling and storing device |
US9527241B2 (en) | 2013-12-20 | 2016-12-27 | Xerox Corporation | Three dimensional (3D) printing of epoxy, hardener, and parts of an object to be assembled later |
CN104306029A (en) * | 2014-11-04 | 2015-01-28 | 温鑫 | Developing tissue exudate sampling and detection device |
CN106190801A (en) * | 2016-07-17 | 2016-12-07 | 佛山市大臻医学检验所有限公司 | Separate type sampling swab for oral cavity |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522302A (en) * | 1984-03-05 | 1985-06-11 | Sterling Drug Inc. | Pre-sterilized medical procedure kit packages |
EP0442600A2 (en) * | 1990-02-11 | 1991-08-21 | Charles Terrence Macartney | Biological sample collection tube |
US5164504A (en) | 1991-01-16 | 1992-11-17 | Abbott Laboratories | Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives |
EP0734686A1 (en) * | 1995-03-30 | 1996-10-02 | Ortho Pharmaceutical Corporation | In home oral fluid sample collection device and package for mailing of such device |
WO1997020502A1 (en) * | 1995-12-01 | 1997-06-12 | Lamprecht Ag | Saliva sampling device |
US5830410A (en) | 1989-09-21 | 1998-11-03 | Epitope, Inc. | Oral collection device and kit |
-
2000
- 2000-10-17 AU AU78085/00A patent/AU7808500A/en not_active Abandoned
- 2000-10-17 CN CN00814413A patent/CN1379641A/en active Pending
- 2000-10-17 EP EP00968131A patent/EP1223866A1/en not_active Withdrawn
- 2000-10-17 CA CA002386987A patent/CA2386987A1/en not_active Abandoned
- 2000-10-17 JP JP2001531028A patent/JP2003511186A/en not_active Withdrawn
- 2000-10-17 WO PCT/GB2000/003983 patent/WO2001028428A1/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522302A (en) * | 1984-03-05 | 1985-06-11 | Sterling Drug Inc. | Pre-sterilized medical procedure kit packages |
US5830410A (en) | 1989-09-21 | 1998-11-03 | Epitope, Inc. | Oral collection device and kit |
EP0442600A2 (en) * | 1990-02-11 | 1991-08-21 | Charles Terrence Macartney | Biological sample collection tube |
US5164504A (en) | 1991-01-16 | 1992-11-17 | Abbott Laboratories | Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives |
EP0734686A1 (en) * | 1995-03-30 | 1996-10-02 | Ortho Pharmaceutical Corporation | In home oral fluid sample collection device and package for mailing of such device |
WO1997020502A1 (en) * | 1995-12-01 | 1997-06-12 | Lamprecht Ag | Saliva sampling device |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1389445A2 (en) * | 2002-08-14 | 2004-02-18 | Cozart Bioscience Limited | An oral fluid collection, testing and transportation device and method |
EP1389445A3 (en) * | 2002-08-14 | 2004-05-19 | Cozart Bioscience Limited | An oral fluid collection, testing and transportation device and method |
EP1692255A2 (en) * | 2003-11-12 | 2006-08-23 | Trustees Of Boston University | Isolation of nucleic acid from mouth epithelial cells |
EP1692255A4 (en) * | 2003-11-12 | 2010-12-08 | Univ Boston | Isolation of nucleic acid from mouth epithelial cells |
US10808285B2 (en) | 2005-04-14 | 2020-10-20 | Trustees Of Boston University | Diagnostic for lung disorders using class prediction |
US9920374B2 (en) | 2005-04-14 | 2018-03-20 | Trustees Of Boston University | Diagnostic for lung disorders using class prediction |
US11977076B2 (en) | 2006-03-09 | 2024-05-07 | Trustees Of Boston University | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
US10570454B2 (en) | 2007-09-19 | 2020-02-25 | Trustees Of Boston University | Methods of identifying individuals at increased risk of lung cancer |
US12110554B2 (en) | 2009-05-07 | 2024-10-08 | Veracyte, Inc. | Methods for classification of tissue samples as positive or negative for cancer |
US10731223B2 (en) | 2009-12-09 | 2020-08-04 | Veracyte, Inc. | Algorithms for disease diagnostics |
JP2014153127A (en) * | 2013-02-06 | 2014-08-25 | Railway Technical Research Institute | Specimen sampler for urine dirt of toilet determination, urine dirt of toilet determination kit, and determination method of urine dirt of toilet |
US10526655B2 (en) | 2013-03-14 | 2020-01-07 | Veracyte, Inc. | Methods for evaluating COPD status |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
US11639527B2 (en) | 2014-11-05 | 2023-05-02 | Veracyte, Inc. | Methods for nucleic acid sequencing |
US10927417B2 (en) | 2016-07-08 | 2021-02-23 | Trustees Of Boston University | Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions |
Also Published As
Publication number | Publication date |
---|---|
CA2386987A1 (en) | 2001-04-26 |
EP1223866A1 (en) | 2002-07-24 |
AU7808500A (en) | 2001-04-30 |
JP2003511186A (en) | 2003-03-25 |
CN1379641A (en) | 2002-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001028428A1 (en) | Sample taking device | |
CA2072331C (en) | Sampling device and sample adequacy system | |
US9414813B2 (en) | Device for assaying analytes in bodily fluids | |
US7908935B2 (en) | Feces collection container | |
US20030190259A1 (en) | Apparatus for sampling, storing, preserving and testing a specimen | |
US5776078A (en) | Cassette holder for capillary tube blood testing with integral sealing means | |
US4873193A (en) | Method and apparatus for the collection and preservation of fluid biological evidence | |
US20100077843A1 (en) | Substance identification apparatus and methods of using | |
US6277646B1 (en) | Fluid specimen collecting and testing apparatus | |
KR101157810B1 (en) | Medical Device package, Kit and associated methods | |
US4387725A (en) | Device for use in the collection and transportation of medical specimens | |
US5160329A (en) | Biological fluid specimen collection bag | |
JPH09504871A (en) | Analytical device and its use | |
CA2286910A1 (en) | Fluid specimen collecting and testing apparatus | |
WO2006066090A2 (en) | Adapter for attaching information to test tubes | |
US20100124517A1 (en) | Device for performing rapid 'on-site' tests of biological fluids | |
US5217443A (en) | Biological fluid specimen collection bag | |
GB2355525A (en) | Sampling device for oral cavity | |
US20040228767A1 (en) | Auto-sealing specimen container | |
CA1306723C (en) | Method and apparatus for the collection and transportation of dual biological evidence | |
ES2523682B1 (en) | Drug Abuse Detection System | |
GB2230768A (en) | Container closures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2386987 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008144133 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 531028 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 78085/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000968131 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10110873 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000968131 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000968131 Country of ref document: EP |